{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:43:00Z","timestamp":1790257380150,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bcmd.2012.11.002","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T06:45:42Z","timestamp":1353912342000},"page":"184-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hsp90 \u2014 a potential prognostic marker in CML"],"prefix":"10.1016","volume":"50","author":[{"given":"Mark\u00e9ta","family":"\u017d\u00e1\u010dkov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darina","family":"Mou\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Lopotov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Ondr\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Klamov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Moravcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2012.11.002_bb0005","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year followup of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0015","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2007-08-109330","article-title":"Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells","volume":"111","author":"Wu","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcmd.2012.11.002_bb0020","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/107327480901600203","article-title":"Tailoring tyrosine kinase inhibitor therapy in chronic myeloid leukemia","volume":"16","author":"Mauro","year":"2009","journal-title":"Cancer Control"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbf.1609","article-title":"Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators","volume":"28","author":"Henderson","year":"2010","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0030","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/ijc.22403","article-title":"Inhibition of heat shock protein-90 modulates multiple functions required for survival of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells","volume":"120","author":"Kawakami","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12038-007-0051-y","article-title":"Heat shock protein 90: the cancer chaperone","volume":"32","author":"Neckers","year":"2007","journal-title":"J. Biosci."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0045","first-page":"355","article-title":"The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome","volume":"11","author":"An","year":"2000","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0050","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/leu.2008.89","article-title":"Disruption of the Bcr-Abl\/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin","volume":"22","author":"Wu","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0055","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2004-05-2041","article-title":"Mechanistic role of heat shock protein 70 in Bcr-Abl\u2013mediated resistance to apoptosis in human acute leukemia cells","volume":"105","author":"Guo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.leu.2404463","article-title":"Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia","volume":"21","author":"Pocaly","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/153537020322800201","article-title":"Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery","volume":"228","author":"Pratt","year":"2003","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0070","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.1074\/jbc.M206566200","article-title":"The assembly and intermolecular properties of the hsp70-Hop-hsp90 molecular chaperone complex","volume":"277","author":"Hernandez","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0075","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/ijc.24572","article-title":"Heat-shock protein pretreatment inhibits sorbitol-induced apoptosis in K562, U937 and HeLa cells","volume":"125","author":"Marfe","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<75::AID-IJC13>3.0.CO;2-4","article-title":"Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetinused in combination: role of heat-shock protein-70","volume":"73","author":"Larroca","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0085","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/ijc.22974","article-title":"Drug-induced Myc-mediated apoptosis of cancer cells is inhibited by stress protein HSP70","volume":"121","author":"Afanasyeva","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0090","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.leu.2402257","article-title":"The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy","volume":"15","author":"Blagosklonny","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0095","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood-2002-05-1361","article-title":"BCR-ABL point mutants isolated from patients with imatinib mesylate\u2013resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90","volume":"100","author":"Gorre","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0100","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2174\/092986708786242895","article-title":"Novobiocin additional inhibitors of the HSP90 C-terminal nuckleotide-binding pocket","volume":"15","author":"Donnelly","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcmd.2012.11.002_bb0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bcp.2008.10.019","article-title":"HSP 90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death","volume":"77","author":"Beck","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0110","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/annonc\/mdg316","article-title":"The Hsp90 complex as a novel target for cancer therapy","volume":"14","author":"Goetz","year":"2003","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.bcmd.2012.11.002_bb0115","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0006-2952(98)00120-8","article-title":"The Hsp90 complex\u2014a super-chaperone machine as a novel drug target","volume":"56","author":"Scheibela","year":"1998","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcmd.2012.11.002_bb0120","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2012.11.002_bb0125","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.leukres.2006.07.021","article-title":"The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR","volume":"31","author":"Rulcov\u00e1","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcmd.2012.11.002_bb0135","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1349-7006.2007.00561.x","article-title":"Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis","volume":"98","author":"Tsutsumi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.leukres.2008.07.012","article-title":"Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia","volume":"33","author":"Yeh","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1196\/annals.1391.019","article-title":"Extracellular heat shock proteins in cell signaling and immunity","volume":"1113","author":"Calderwood","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcmd.2012.11.002_bb0150","article-title":"A significant proportion of patients with chronic myeloid leukemia and suboptimal response according to European Leukemia Net criteria have excellent prognosis without treatment change","author":"Rohon","year":"2011","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979612001982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979612001982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:02Z","timestamp":1761049742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979612001982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1079979612001982"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2012.11.002","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hsp90 \u2014 a potential prognostic marker in CML","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2012.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}